A -Squared Ventures

Connecting the Dots for Exponential Growth

A-Squared Ventures

Connecting the Dots for Exponential Growth

decorative

A-Squared

Early-Stage Partners
in Healthtech Innovation

A² supports and funds early-stage entrepreneurs harnessing software to address unmet business needs in healthcare. We invest in B2B and B2B2C healthcare IT, tech-centered services, and pharma-tech companies operating in the US market.

 
decorative

Connecting

Innovation
& Impact

We believe innovating in healthcare is a business challenge, not just a tech one. We strive to use our network and experience to lower barriers for founders and provide access to customers, capital, and market knowledge.

  • Founded In 2021

  • Portfolio
    Companies
    13

  • From First Capital to Series A

How A²

Helps You
Scale Smarter

From Israel to the US and beyond, we’ve built a high-conviction platform designed to help founders tackle the toughest hurdles in digital health – access, market fit, and exponential growth.

  • Dual
    Market
    Presence
    alt
    On-the-ground teams in Tel Aviv and Northeast US
  • decorative
    In the
    Trenches
    With You
    alt
    Hands-on support in refining your GTM strategy, validating your ideal customer profile, and building the commercial clarity to scale with confidence.
  • Data
    Driven
    Edge
    alt
    Proprietary database of 3,000+ companies, real-time market signals, and rapid feedback loops - turning conviction into execution faster.
  • Strategic
    Access
    alt
    Network of over 250 VC funds and 350+ senior healthcare experts for instant signal, and faster connections.
decorative
decorative
A² Unique Edge Powered by Arkin
Arkin Capital is a leading multi-asset investment manager, with over $2 billion under management across 12 funds. Through its four investment arms - Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate - with a core strength in healthcare and life sciences built over more than 15 years of focused activity. A² leverages Arkin Capital’s infrastructure and extensive cross-sector expertise, backed by over 30 successful exits.

Our
Portfolio

Why
Founders
Choose

And Stick
With A²

Yoni
Shtein

CEO & Founder at Laguna Health

“Working with Nadav and the A-Squared team provides unparalleled value to digital health entrepreneurs! From lead investor to lead advisor introductions, their caring, mindful, and respectful approach to tangible value creation is profound! Having been an investor for years, I personally know the difference between value-add, neutral, and harmful investors – Nadav is deeply in the first category”

Alon
Joffe

CEO and founder
at Eleos

“We have known Nadav and Sam even before they joined us in our Seed round, and since then, they have been true partners the kind that understand the difficulties of innovating in healthcare and are in your corner through both highs and lows”

Trey
Sutten

CEO and founder
at Siftwell

“Nadav and Sam have been exceptional partners throughout our journey, and their support has only deepened as we work together more closely. They are incredibly responsive and thoughtful in addressing our requests for advice and connections, always going above and beyond to add value. Nadav has been a fantastic addition to our board, consistently coming prepared and eager to understand how to best support the management team and drive our organization forward. His insights and strategic thinking have been invaluable in helping us accelerate our growth. I would highly recommend A-Squared to any founder looking for a dedicated, insightful, and proactive investor team in the space”

Yoni
Shtein

CEO & Founder at Laguna Health

Alon
Joffe

CEO and founder
at Eleos

Trey
Sutten

CEO and founder
at Siftwell

“Working with Nadav and the Arkin Digital Health team provides unparalleled value to digital health entrepreneurs!

From lead investor to lead advisor introductions, their caring, mindful, and respectful approach to tangible value creation is profound!

Having been an investor for years, I personally know the difference between value-add, neutral, and harmful investors – Nadav is deeplyin the first category”

“We have known Nadav and Sam even before they joined us in our Seed round,

and since then, they have been true partners the kind that understand the difficulties of innovating in healthcare and are in your corner through both highs and lows”

“Nadav and Sam have been exceptional partners throughout our journey, and their support has only deepened as we work together more closely. They are incredibly responsive and thoughtful in addressing our requests for advice and connections, always going above and beyond to add value.

Nadav has been a fantastic addition to our board, consistently coming prepared and eager to understand how to best support the management team and drive our organization forward. His insights and strategic thinking have been invaluable in helping us accelerate our growth.

I would highly recommend A-Squared to any founder looking for a dedicated, insightful, and proactive investor team in the space”

Meet the
A² Team

decorative
 

Dr. Nadav Shimoni

Managing Partner

Dr. Nadav Shimoni established and serves as Managing Partner at A². In this role, Nadav oversees the fund's activities, including deal sourcing, due diligence processes, and ongoing support for portfolio companies. He serves on the board of Laguna, Rhino, Medminder, Eleos, Validic and Siftwell and No Barrier.

Dr. Shimoni is a physician by training. Prior to A², he served as the Director of Hospital Business Development at Clalit Health Services, Head of Business Development at Rambam Medical Center, and as an Associate at Accelmed, a medical device VC. In parallel, he conducted public health research focused on the implementation of data and AI-driven solutions in clinical workflows.

Dr. Shimoni holds an M.D. from Ben-Gurion University, graduating magna cum laude.

 

Dr. Sam Cronin

Partner

Sam Cronin joined A² Ventures in 2021 and leads the Israel-based activities. He is
responsible for deal sourcing, due diligence, portfolio management, and fostering outreach
within the local healthcare ecosystem. Sam sits on the boards of Edocate, Revisto and
Gracey.

Prior to joining A², Sam headed the digital health vertical at the UK Israel Tech Hub,
where he provided boutique innovation consulting to diverse healthcare multinationals
such as AstraZeneca, Walgreens Boots Alliance, Elsevier, and the NHS.

Sam holds advanced degrees across pharmacology, biotechnology and medical devices,
from both the University of Leeds and Ben-Gurion University, and before moving to Israel
worked in corporate finance conducting financial forensic investigations in the City of
London. He is a fellow in medical innovation at UCL (UK) and a guest lecturer at several
Israeli universities.

 

Jason Zilberkweit

Senior Associate & Platform Lead

Jason Zilberkweit joined A-Squared in 2025 and leads platform development while cross-functionally supporting fund activities. He is responsible for the efficient coordination of the firms resources, partners and broader network to create alignment and generate value across the platform. Prior to joining A-Squared, Jason led the North American insurance advisory practice at SOSA, a global innovation consultancy, working with innovation and CVC teams to design corporate venture strategy and execution through effective partnership development with emerging tech. Jason holds a B.S. In Computer Science with a minor in finance from NYU. Based in NYC, Jason began his career as a software engineer before spending the past 5 years in various strategy & operations consulting roles.

A² Advisory Board
Guiding Global Vision

decorative
Dr.<br />
René Lerer
Dr.<br />
René Lerer
 

Dr.
René Lerer

Executive Chairman

Dr. <br />
Deneen Vojta
Dr. <br />
Deneen Vojta
 

Dr.
Deneen Vojta

EVP, Healthcare Quality and Affordability

Dr. <br />
David Shulkin
Dr. <br />
David Shulkin
 

Dr.
David Shulkin

9th Secretary, U.S. Department of Veterans Affair

Dr. <br />
Steve Klasko
Dr. <br />
Steve Klasko
 

Dr.
Steve Klasko

Ex. CEO

Darren <br />
Dworkin
Darren <br />
Dworkin
 

Darren
Dworkin

COO & President

Dr.
René Lerer

Executive Chairman

Executive Chairman of Longevity Health Plan. Formerly President of GuideWell Mutual Holding Corporation, the parent company of Florida Blue. Before GuideWell, Dr. Lerer was the Executive Chairman and CEO of Magellan Health Services, now Magellan Health.

Dr.
Deneen Vojta

EVP, Healthcare Quality and Affordability

Executive Vice President, Health Solutions at Blue Shield of California. Formerly Executive Vice President of Research and Development at UnitedHealth Group (2005–2021), the largest commercial health plan in the US. Before joining UnitedHealth, Dr. Vojta founded and managed MYnetico, which fought the epidemic of childhood obesity.

Dr.
David Shulkin

9th Secretary, U.S. Department of Veterans Affair

The Ninth Secretary of the U.S. Department of Veterans Affairs under the Trump and Obama administrations. The Ninth Secretary of the U.S. Department of Veterans Affairs under the Trump and Obama administrations. Dr. David Shulkin has held several senior positions in management and leadership of public health systems across the country.

Dr.
Steve Klasko

Ex. CEO

Formerly President and CEO of Thomas Jefferson Medical Center and Jefferson University (2013–2021). Formerly President and CEO of Thomas Jefferson Medical Center and Jefferson University (2013–2021), a health system with 14 hospitals and an insurer for two million patients in Philadelphia and New Jersey. Previously, Dr. Klasko served as Dean of the school of medicine and Director of the University of South Florida Medical Center.

Darren
Dworkin

COO & President

Chief Operations Officer and President at Press Ganey and Managing Partner at Press Ganey Ventures. Press Ganey enhances patient and customer experiences for more than 10,000 hospitals worldwide, with a particular focus on the U.S. market. Previously, Mr. Dworkin served as Chief Information Officer at Cedars-Sinai Health System and was Managing Director of Cedars-Sinai Ventures.

 

Stay Ahead with A²

Dive into our latest articles, news, and events to gain valuable information and stay connected to the front lines of digital health innovation.

המאבק הפוליטי בארצות הברית מאיים על ביטוחי הבריאות הציבוריים

נוב 2025

Read More >

גל מיזוגים ורכישות הולך ומתעצם

אוק 2025

Read More >

אפיק מכניסה את התעשייה לסחרור

ספט 2025

Read More >

התחרות בשוק התמלול עולה מדרגה

אוג 2025

Read More >

החוק הגדול והיפה והשפעותיו על תעשיית הבריאות האמריקאית

יול 2025

Read More >

The biggest financial risk for digital health investors in the AI era

Jul 2025

Read More >